The present invention relates to novel phenylaminopyrimidine(FAP)-derived compounds of general formulas I and II:Where, in formula I, R1 is:Where, in formula II, X+ is selected among one of the compounds below:Where, in formula II, Y isThe compounds of the present invention are powerful and nonspecific tyrosine kinase inhibitors, and the use of these compounds in the treatment.